TY - JOUR
T1 - Target Sequencing, Cell Experiments, and a Population Study Establish Endothelial Nitric Oxide Synthase (eNOS) Gene as Hypertension Susceptibility Gene
AU - Salvi, Erika
AU - Kuznetsova, Tatiana
AU - Thijs, Lutgarde
AU - Lupoli, Sara
AU - Stolarz-Skrzypek, Katarzyna
AU - D'Avila, Francesca
AU - Tikhonoff, Valerie
AU - De Astis, Silvia
AU - Barcella, Matteo
AU - Seidlerova, Jitka
AU - Benaglio, Paola
AU - Malyutina, Sofia
AU - Frau, Francesca
AU - Velayutham, Dinesh
AU - Benfante, Roberta
AU - Zagato, Laura
AU - Title, Alexandra
AU - Braga, Daniele
AU - Marek, Diana
AU - Kawecka-Jaszcz, Kalina
AU - Casiglia, Edoardo
AU - Filipovsky, Jan
AU - Nikitin, Yuri
AU - Rivolta, Carlo
AU - Manunta, Paolo
AU - Beckmann, Jacques S.
AU - Barlassina, Cristina
AU - Cusi, Daniele
AU - Staessen, Jan A.
PY - 2013/11
Y1 - 2013/11
N2 - A case-control study revealed association between hypertension and rs3918226 in the endothelial nitric oxide synthase (eNOS) gene promoter (minor/major allele, T/C allele). We aimed at substantiating these preliminary findings by target sequencing, cell experiments, and a population study. We sequenced the 140-kb genomic area encompassing the eNOS gene. In HeLa and HEK293T cells transfected with the eNOS promoter carrying either the T or the C allele, we quantified transcription by luciferase assay. In 2722 randomly recruited Europeans (53.0% women; mean age 40.1 years), we studied blood pressure change and incidence of hypertension in relation to rs3918226, using multivariable-adjusted models. Sequencing confirmed rs3918226, a binding site of E-twenty six transcription factors, as the single nucleotide polymorphism most closely associated with hypertension. In T compared with C transfected cells, eNOS promoter activity was from 20% to 40% (P
AB - A case-control study revealed association between hypertension and rs3918226 in the endothelial nitric oxide synthase (eNOS) gene promoter (minor/major allele, T/C allele). We aimed at substantiating these preliminary findings by target sequencing, cell experiments, and a population study. We sequenced the 140-kb genomic area encompassing the eNOS gene. In HeLa and HEK293T cells transfected with the eNOS promoter carrying either the T or the C allele, we quantified transcription by luciferase assay. In 2722 randomly recruited Europeans (53.0% women; mean age 40.1 years), we studied blood pressure change and incidence of hypertension in relation to rs3918226, using multivariable-adjusted models. Sequencing confirmed rs3918226, a binding site of E-twenty six transcription factors, as the single nucleotide polymorphism most closely associated with hypertension. In T compared with C transfected cells, eNOS promoter activity was from 20% to 40% (P
KW - blood pressure
KW - endothelial nitric oxide synthase gene
KW - hypertension
KW - population science
KW - target sequencing
KW - transfection
U2 - 10.1161/HYPERTENSIONAHA.113.01428
DO - 10.1161/HYPERTENSIONAHA.113.01428
M3 - Article
C2 - 24019403
SN - 0194-911X
VL - 62
SP - 844
EP - 852
JO - Hypertension
JF - Hypertension
IS - 5
ER -